Tepkinly

(epcoritamab)

Uses, side effects, dosage information & price range

AbbVie Deutschland GmbH & Co. KG

About this medicine

Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy.Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.Tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL) after two or more lines of systemic therapy. 

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

PoherdyComposition: pertuzumabOrganon N.V.

Price on RequestView Details →

MekinistComposition: trametinibNovartis Europharm Limited

Price on RequestView Details →

VijoiceComposition: alpelisibNovartis Europharm Limited

Price on RequestView Details →

KisqaliComposition: ribociclibNovartis Europharm Limited

Price on RequestView Details →

TecartusComposition: brexucabtagene autoleucelKite Pharma EU B.V.

Price on RequestView Details →

Key Information

Salt / Composition

epcoritamab